UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

BMC medical research methodology, 2020-09, Vol.20 (1), p.223-223, Article 223

2020

Volltextzugriff (PDF)

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

Quality of life research, 2020-04, Vol.29 (4), p.867-878

2020

Volltextzugriff (PDF)

Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study

British journal of cancer, 2017-03, Vol.116 (7), p.849-858

2017

Volltextzugriff (PDF)

TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

Computer methods and programs in biomedicine, 2022-02, Vol.214, p.106537-106537, Article 106537

2022

Volltextzugriff (PDF)

REMISSION AFTER CAR T‐CELLS: DO PATIENTS RECOVER A NORMAL LIFE?

Hematological oncology, 2023-06, Vol.41 (S2), p.786-787

2023

Volltextzugriff (PDF)

LIFE AFTER CAR‐T CELLS: A PROSPECTIVE STUDY EVALUATING THE PERSONAL, SOCIAL AND PROFESSIONAL OUTCOMES AFTER CAR‐T CELL THERAPY IN LYMPHOMA PATIENTS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

Trials, 2019-06, Vol.20 (1), p.375-375, Article 375

2019

Volltextzugriff (PDF)

Quality of life and response shift effect of diffuse large B‐cell lymphoma French patients included in prospective real‐life REALYSA cohort in the first year after diagnosis

Hematological oncology, 2023-06, Vol.41 (S2), p.428-429

2023

Volltextzugriff (PDF)

3054 Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial

European journal of cancer (1990), 2015-09, Vol.51, p.S613-S614

2015

Volltextzugriff (PDF)

Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT‐C33) and specific complementary outpatient module (EORTC OUT‐PATSAT7)

European journal of cancer care, 2018-01, Vol.27 (1), p.e12786-n/a

2018

Volltextzugriff (PDF)

Evaluation properties of the French version of the OUT-PATSAT35 satisfaction with care questionnaire according to classical and item response theory analyses

Quality of life research, 2014-09, Vol.23 (7), p.2089-2101

2014

Volltextzugriff (PDF)

2376 Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (datecan-2): an analysis of 9 pancreatic cancer trials

European journal of cancer (1990), 2015-09, Vol.51, p.S462-S462

2015

Volltextzugriff (PDF)

Consensus Patients pour des REcherches en soins de Support : projet CyPRES

Oncologie (Paris, France), 2017, Vol.19 (1-2), p.21-25

2017

Volltextzugriff (PDF)

Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies

Annales pharmaceutiques françaises, 2016-11, Vol.74 (6), p.439-447

2016

Volltextzugriff (PDF)

P007 - The French version of the Missoulas Vitas Quality of Life Index in oncology palliative care setting: a cross-cultural adaptation and psychometric assessment

Revue d'épidémiologie et de santé publique, 2023-05, Vol.71, p.101648, Article 101648

2023

Volltextzugriff (PDF)

1262MO Impact of a minimal versus CT-scan-based follow-up on patient-reported outcomes for completely resected non-small cell lung cancer (NSCLC) in phase III IFCT-0302 trial

Annals of oncology, 2023-10, Vol.34, p.S732-S732

2023

Volltextzugriff (PDF)

Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort

European journal of cancer (1990), 2024-09, Vol.208, p.114210, Article 114210

2024

Volltextzugriff (PDF)

Emotional distress, supportive care needs and age in the prediction of quality of life of cancer patients’ caregivers: A cross-sectional study

European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2023-06, Vol.64, p.102324-102324, Article 102324

2023

Volltextzugriff (PDF)

Response shift results of quantitative research using patient-reported outcome measures: a descriptive systematic review

Quality of life research, 2024-02, Vol.33 (2), p.293-315

2024

Volltextzugriff (PDF)

LBA12 eMouvoir: Randomised phase III trial evaluating the impact of a personalized and remote physical activity (PA) for breast cancer survivors (BCS). Results on the quality of life (QoL)

Annals of oncology, 2024-09, Vol.35, p.S1206-S1206

2024

Volltextzugriff (PDF)

1249P Health-related quality of life (HRQoL) at diagnosis for unresectable stage III NSCLC: Results from the French nationwide prospective study OBSTINATE (GFPC 06-2019)

Annals of oncology, 2024-09, Vol.35, p.S799-S800

2024

Volltextzugriff (PDF)

HTA104 Opportunities to Improve the Adoption of Quality of Life Data as Part of the French Health Technology Assessment Process

Value in health, 2022-12, Vol.25 (12), p.S316-S316

2022

Volltextzugriff (PDF)

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Annals of oncology, 2022-09, Vol.33 (7), p.S987-S987

2022

Volltextzugriff (PDF)

962P Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

Annals of oncology, 2022-09, Vol.33, p.S987

2022

Volltextzugriff (PDF)

CO7.4 - Evolution de la qualité de vie des patients atteints d'un lymphome diffus à grandes cellules B après la première ligne de traitement et participant à la cohorte prospective REALYSA

Journal of Epidemiology and Population Health, 2024-05, Vol.72, p.202423, Article 202423

2024

Volltextzugriff (PDF)

1 – 25 von 409

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(342)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17

Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review

Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study

TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology

REMISSION AFTER CAR T‐CELLS: DO PATIENTS RECOVER A NORMAL LIFE?

LIFE AFTER CAR‐T CELLS: A PROSPECTIVE STUDY EVALUATING THE PERSONAL, SOCIAL AND PROFESSIONAL OUTCOMES AFTER CAR‐T CELL THERAPY IN LYMPHOMA PATIENTS

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study

Quality of life and response shift effect of diffuse large B‐cell lymphoma French patients included in prospective real‐life REALYSA cohort in the first year after diagnosis

3054 Health-related quality of life in elderly patients with advanced non-small-cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy in the Phase 3 IFCT-0501 trial

Phase III study of the European Organisation for Research and Treatment of Cancer satisfaction with cancer care core questionnaire (EORTC PATSAT‐C33) and specific complementary outpatient module (EORTC OUT‐PATSAT7)

Evaluation properties of the French version of the OUT-PATSAT35 satisfaction with care questionnaire according to classical and item response theory analyses

2376 Impact of the definition of time to event endpoint on randomized clinical trials results in oncology (datecan-2): an analysis of 9 pancreatic cancer trials

Consensus Patients pour des REcherches en soins de Support : projet CyPRES

Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies

P007 - The French version of the Missoulas Vitas Quality of Life Index in oncology palliative care setting: a cross-cultural adaptation and psychometric assessment

1262MO Impact of a minimal versus CT-scan-based follow-up on patient-reported outcomes for completely resected non-small cell lung cancer (NSCLC) in phase III IFCT-0302 trial

Health-related quality of life profile of newly diagnosed patients with Hodgkin and non-Hodgkin lymphomas: A real-world study including 3922 patients from the French REALYSA cohort

Emotional distress, supportive care needs and age in the prediction of quality of life of cancer patients’ caregivers: A cross-sectional study

Response shift results of quantitative research using patient-reported outcome measures: a descriptive systematic review

LBA12 eMouvoir: Randomised phase III trial evaluating the impact of a personalized and remote physical activity (PA) for breast cancer survivors (BCS). Results on the quality of life (QoL)

1249P Health-related quality of life (HRQoL) at diagnosis for unresectable stage III NSCLC: Results from the French nationwide prospective study OBSTINATE (GFPC 06-2019)

HTA104 Opportunities to Improve the Adoption of Quality of Life Data as Part of the French Health Technology Assessment Process

Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

962P Quality of life at diagnosis for unresectable stage III NSCLC: Initial results from the national prospective study OBSTINATE (GFPC 06-2019)

CO7.4 - Evolution de la qualité de vie des patients atteints d'un lymphome diffus à grandes cellules B après la première ligne de traitement et participant à la cohorte prospective REALYSA

Suchergebnisse filtern